Moderate coding emphasis
DevOps interviews focus more on scripting and automation than complex algorithms. Expect Python/Bash scripting, data parsing, and basic data structures.
1 roles from funded startups and hidden sources. Posted
minutes ago. Updated every 60 seconds
Focus areas that matter most for infrastructure and automation roles.. Explore key insights and preparation tips to help you excel in your interview process.
DevOps interviews focus more on scripting and automation than complex algorithms. Expect Python/Bash scripting, data parsing, and basic data structures.
Design scalable deployment pipelines, monitoring systems, and cloud architectures. Heavy emphasis on reliability and automation.
CI/CD
Pipeline Architecture
Monitoring
Observability Systems
Cloud
Infrastructure as Code
Different companies emphasize different aspects of DevOps expertise and tooling preferences.
Netflix
Chaos engineering and microservices reliability
Stripe
Payment infrastructure and security compliance
Compare cost-of-living buying power and how crowded the market is versus other major tech cities—so you can focus your search where the odds fit your goals.
Philadelphia offers DevOps Engineers approximately 68% lower housing costs compared to San Francisco, with median home prices around $280K versus $1.4M+ in the Bay Area. Your tech salary stretches significantly further while maintaining access to major East Coast markets and a thriving startup ecosystem.
Philadelphia's DevOps market shows healthy demand with manageable competition, especially compared to oversaturated West Coast hubs.

New roles go live every minute and the earliest applicants win. Get the freshest, verified listings delivered straight to your inbox before most job seekers ever see them.
👉 Get free daily job postsVerismo Therapeutics is a clinical-stage cell therapy company developing a multi-chain KIR-CAR platform that adapts NK-cell killer immunoglobulin-like receptor and DAP12 signaling to extend CAR T cell therapy beyond blood cancers into solid tumors. Founded by inventors of the Kymriah CAR-T (including Carl June), the company is advancing two Phase 1 programs: SynKIR-110 in mesothelin-positive solid tumors and SynKIR-310 in relapsed/refractory B cell non-Hodgkin lymphoma. It is a U.S. subsidiary of KOSDAQ-listed HLB Innovation.
Raised
$28M
Series B · 2026
Key contacts
-
Leadership & hiring contacts indexed
HQ market
Philadelphia, Pennsylvania
United States
Philadelphia-based healthcare technology company providing AI-driven automation for prior authorization. The platform stitches together the healthcare ecosystem by empowering providers and health systems to navigate the prior authorization process more efficiently, reducing administrative burden and accelerating patient access to care.
Raised
$8.5M
Series A · 2026
Key contacts
-
Leadership & hiring contacts indexed
HQ market
Philadelphia , Pennsylvania
United States